Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls
Clinical trial NCT05393076 · COMPLETED
Trial details
- NCT number
- NCT05393076
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2022-12-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.